XML 127 R105.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair value measurement - Contingent Consideration Obligations (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Fair Value Disclosures [Abstract]      
Beginning balance $ 33 $ 61 $ 72
Additions 309 0 0
Payments (7) (6) 0
Net changes in valuations 7 (22) (11)
Ending balance 342 $ 33 $ 61
Teneobio, Inc.      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 1,600